Cinaciguat
Cinaciguat (BAY 58-2667) is a pioneering soluble guanylate cyclase (sGC) activator developed for treating acute decompensated heart failure. It is widely used in cardiovascular research to study sGC function and hemodynamics in both in vitro assays and in vivo heart failure models.
Product Specifications
CAS Number
329773-35-5
Product Name Alternative
Inhibit, Inhibitor, Guanylatecyclase, guanylate cyclase, Guanylate Cyclase, Guanylate cyclase, Cinaciguat, BAY 58-2667
Field of Research
Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:45 mg/mL (79.55 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (3.54 mM)
Smiles
O (CC1=CC=C (CCC2=CC=CC=C2) C=C1) C3=C (CCN (CC4=CC=C (C (O) =O) C=C4) CCCCC (O) =O) C=CC=C3
Molecular Formula
C36H39NO5
Molecular Weight
565.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
252229-ML550 100 µL
STMN2 (Stathmin-like 2, SCG10, SCGN10, SGC10) (MaxLight 550)
Sign In for Pricing
View Details 
GTR15258101 1 Vial
Lentiviral mouse Dscaml1 shRNA (UAS) - Lentiviral mouse Dscaml1 shRNA (UAS) (25)
Sign In for Pricing
View Details bs-8996R-PE-Cy5-01 20 µL
CD34 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details